San Francisco, CA. , June 13, 2018 (GLOBE NEWSWIRE) -- Vet Online Supply, Inc. (OTC PINK:VTNL) (“Vet Online Supply” or the “Company”), the rapidly growing CBD Pet product company, today announced that the company is evaluating the pharmaceutical potential in a new brand of their products for human consumption in the European CBD Market while launching their Pet CBD Products in the European Community later this month.

Daniel Rushford, CEO and Chairman, Stated, “Europe’s market potential for cannabidiol (CBD) is pegged at around 2.4 billion dollars as a treatment for chronic diseases, according to a new report by nova-Institute and Hemp-Consult (both of Germany), who probed the market for non-psychotropic CBD, increasingly in demand as a food supplement and pharmaceutical. Our existing products target the same illnesses in pets, and our team of experts is now opening doors to process our formulas under strict pharmaceutical guidelines in the European Market place. We anticipate investing in this new development over the next 12 months and will keep our shareholders informed of this exciting progress.”

According to the American Pet Products Association the industry for 2018 is at $72B. Vet Online Supply will seek to be a major player in the holistic CBD Pet Product Market for 2018.

www.vetonlinesupplies.com

ABOUT VET ONLINE SUPPLY:

Vet Online Supply Inc., the company, manufactures its own brand of holistic pet products to promote health and well being. The goal of "Vet Online Supply" is to provide the $38B industry with value priced and superior quality holistic pet products.

Safe Harbor for Forward-Looking Statements: This news release includes forward-looking statements. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The Company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are and will be set forth in the company's periodic filings with the U.S. Securities and Exchange Commission.

Contact: Meridian Consulting 323-364-3793